J. Alzheimers Dis.

Obesity-Associated Neurodegeneration Pattern Mimics Alzheimer's Disease in an Observational Cohort Study.

Morys F, Potvin O, Zeighami Y, ..., Dagher A, Alzheimer’s Disease Neuroimaging Initiative

J. Alzheimers Dis. 91 (3) 1059-1071 [2022-12-25; online 2022-12-25]

DDLS Fellow Jacob W Vogel

Dual Bioorthogonal Labeling of the Amyloid-β Protein Precursor Facilitates Simultaneous Visualization of the Protein and Its Cleavage Products.

van Husen LS, Schedin-Weiss S, Trung MN, ..., Elsässer SJ, Tjernberg LO

J. Alzheimers Dis. 72 (2) 537-548 [2019-10-15; online 2019-10-15]

SciLifeLab Fellow Simon Elsässer

Increased Levels of Extracellular Microvesicle Markers and Decreased Levels of Endocytic/Exocytic Proteins in the Alzheimer's Disease Brain.

Musunuri S, Khoonsari PE, Mikus M, ..., Nilsson P, Kultima K

J. Alzheimers Dis. 54 (4) 1671-1686 [2016-10-18; online 2016-10-22]

Affiliated researcher

AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics.

Eketjäll S, Janson J, Kaspersson K, ..., Alexander RC, Cebers G

J. Alzheimers Dis. 50 (4) 1109-1123 [2016-02-19; online 2016-02-19]

Affiliated researcher

Development of Immunoassays for the Quantitative Assessment of Amyloid-β in the Presence of Therapeutic Antibody: Application to Pre-Clinical Studies.

Bogstedt A, Groves M, Tan K, ..., McFarlane M, Höglund K

J. Alzheimers Dis. 46 (4) 1091-1101 [2015-09-25; online 2015-09-25]

Affiliated researcher

An Integrated Bioinformatics Approach for Identifying Genetic Markers that Predict Cerebrospinal Fluid Biomarker p-tau181/Aβ1-42 Ratio in ApoE4-Negative Mild Cognitive Impairment Patients.

Sun Y, Bresell A, Rantalainen M, ..., Salter H, Alzheimer Disease Neuroimaging Initiative

J. Alzheimers Dis. 45 (4) 1061-1076 [2015-02-28; online 2015-02-28]

Affiliated researcher

Prognostic polypeptide blood plasma biomarkers of Alzheimer's disease progression.

Yang H, Lyutvinskiy Y, Herukka SK, ..., Rutishauser D, Zubarev RA

J. Alzheimers Dis. 40 (3) 659-666 [2014-02-08; online 2014-02-08]

Affiliated researcher

Blood plasma IgG Fc glycans are significantly altered in Alzheimer's disease and progressive mild cognitive impairment.

Lundström SL, Yang H, Lyutvinskiy Y, ..., Soininen H, Zubarev RA

J. Alzheimers Dis. 38 (3) 567-579 [2013-09-14; online 2013-09-14]

Affiliated researcher

Shotgun brain proteomics reveals early molecular signature in presymptomatic mouse model of Alzheimer's disease.

Yang H, Wittnam JL, Zubarev RA, Bayer TA

J. Alzheimers Dis. 37 (2) 297-308 [2013-09-11; online 2013-09-11]

Affiliated researcher

Elevated MARK2-dependent phosphorylation of Tau in Alzheimer's disease.

Gu GJ, Wu D, Lund H, ..., Landegren U, Kamali-Moghaddam M

J. Alzheimers Dis. 33 (3) 699-713 [2012-09-25; online 2012-09-25]

Affiliated researcher

Alzheimer's disease and mild cognitive impairment are associated with elevated levels of isoaspartyl residues in blood plasma proteins.

Yang H, Lyutvinskiy Y, Soininen H, Zubarev RA

J. Alzheimers Dis. 27 (1) 113-118 [2011-07-19; online 2011-07-19]

Affiliated researcher